Live Analyst Rating Changes 24957 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Martyn Jacobs
BP

Martyn Jacobs

Bell Potter
Wall Street Analyst
★★★☆☆
#2165
on 13Foresight · ranked by our own returns
49%
Success Rate
-2.9%
Average Return
19 of 39 calls profitable · -13.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 49% of Martyn Jacobs's ratings turned a profit when each position was held for 2 year — averaging -2.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

80 Buy 5 Hold 0 Sell
Martyn's Stock Coverage 21 ratings · 2026-08-16
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
AU:EBR
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
 Aug 13, 2026 BUY Strong Buy
+557.6% avg upside
3 analysts
$0.70
137.28% Upside
 +0.0% ·
AU:SHL
Sonic Healthcare Limited
 Aug 12, 2026 BUY Buy
+14.9% avg upside
12 analysts
$28.75
28.49% Upside
 -0.1% ·
AU:IDX
Integral Diagnostics Ltd.
 Aug 10, 2026 BUY Strong Buy
+38.5% avg upside
12 analysts
$3.60
60.62% Upside
 +0.9% ·
AU:VFY
Vitrafy Life Sciences Ltd.
 Aug 05, 2026 BUY Strong Buy
+9.6% avg upside
2 analysts
$5.15
11.32% Upside
 +21.5% ·
AU:ONE
Oneview Healthcare Chess Depository Interests repr 1
 Jul 30, 2026 BUY Strong Buy
+130.2% avg upside
2 analysts
$0.42
154.50% Upside
 -2.9% ·
AU:BIO
Biome Australia Ltd
 Jul 30, 2026 BUY Strong Buy
+167.9% avg upside
1 analyst
$0.75
167.94% Upside
 +0.0% ·
AU:AYA
Artrya Limited
 Jul 30, 2026 BUY Strong Buy
+26.8% avg upside
1 analyst
$6.10
26.80% Upside
 +19.4% ·
AU:IPD
Impedimed Limited
 Jul 29, 2026 BUY Strong Buy
+1133.3% avg upside
5 analysts
$0.01
66.60% Upside
 +50.0% ·
AU:LDX
Lumos Diagnostics Holdings Ltd.
 Jul 28, 2026 BUY Buy
+263.7% avg upside
2 analysts
$0.25
127.36% Upside
 +10.0% ·
AU:MVP
Medical Developments International Limited
 Jul 26, 2026 BUY Strong Buy
+119.8% avg upside
1 analyst
$1.00
119.77% Upside
 -5.2% ·
AU:MVF
Monash IVF Group Ltd
 Jul 21, 2026 HOLD Strong Buy
+41.4% avg upside
7 analysts
$0.77
10.75% Upside
 +3.7% ·
AU:EMV
EMvision Medical Devices Ltd.
 Jul 16, 2026 BUY Strong Buy
+77.5% avg upside
1 analyst
$3.15
77.53% Upside
 +9.6% ·
AU:AHC
Austco Healthcare Limited
 Jun 01, 2026 BUY Strong Buy
+95.7% avg upside
1 analyst
$0.45
95.74% Upside
 -2.1% ·
AU:TRJ
Trajan Group Holdings Ltd
 May 27, 2026 BUY Strong Buy
+435.1% avg upside
3 analysts
$0.75
294.80% Upside
 -44.1% ·
AU:AT1
Atomo Diagnostics Ltd.
 Oct 31, 2022 HOLD Hold
1 analyst
 — -64.4% ·
AU:RCL
ReadCloud Ltd.
 Oct 31, 2022 HOLD Hold
1 analyst
 — -21.4% ·
AU:NAN
Nanosonics Limited
 Oct 31, 2022 HOLD Hold
+32.4% avg upside
7 analysts
 — -25.1% ·
AU:MYX
Mayne Pharma Group
 Oct 31, 2022 HOLD Hold
+21.2% avg upside
3 analysts
 — -8.4% ·
AU:AMS
Atomos
 Oct 31, 2022 HOLD Hold
1 analyst
 — -72.4% ·
AU:MAP
Microba Life Sciences Limited
 Oct 31, 2022 HOLD Hold
+4.1% avg upside
2 analysts
 — -5.2% ·
AU:PCK
PainChek Ltd
 Oct 31, 2022 HOLD Hold
1 analyst
 — +6.7% ·
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Martyn Jacobs — Frequently Asked Questions
How accurate are Martyn Jacobs's stock ratings?
Based on the calls 13Foresight could measure, about 51% of Martyn's ratings were profitable over a one-year hold, with an average return of -1.4% per rating, or -4.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Martyn ranked on 13Foresight?
Martyn Jacobs is currently ranked #2165 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Martyn cover?
Martyn most recently has ratings on AU:EBR, AU:SHL, AU:IDX, AU:VFY, AU:ONE, AU:BIO, AU:AYA, AU:IPD, AU:LDX, AU:MVP, AU:MVF, AU:EMV and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.